The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Alternative to Antibiotics-Global Market Insights and Sales Trends 2024

Alternative to Antibiotics-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1869969

No of Pages : 127

Ask Your Query
Synopsis
The global Alternative to Antibiotics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alternative to Antibiotics in various end use industries. The expanding demands from the Food & Beverage, Drugs and Dietary Supplements,, are propelling Alternative to Antibiotics market. Antimicrobial Proteins, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bacteriophages segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Alternative to Antibiotics market, driven by demand from China, the second largest economy with some signs of stabilising, the Alternative to Antibiotics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Alternative to Antibiotics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Alternative to Antibiotics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Alternative to Antibiotics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Alternative to Antibiotics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Alternative to Antibiotics covered in this report include DSM, DuPont(Danisco), Chr. Hansen, Lallemand, China-Biotics, Nestle, Danone, Probi and BioGaia, etc.
The global Alternative to Antibiotics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
DSM
DuPont(Danisco)
Chr. Hansen
Lallemand
China-Biotics
Nestle
Danone
Probi
BioGaia
Yakult
Novozymes
Valio
Glory Biotech
Ganeden
Morinaga Milk Industry
Sabinsa
Greentech
Bioriginal
Biosearch Life
UAS Laboratories
Synbiotech
Global Alternative to Antibiotics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Alternative to Antibiotics market, Segment by Type:
Antimicrobial Proteins
Bacteriophages
Probiotics
Other
Global Alternative to Antibiotics market, by Application
Food & Beverage
Drugs
Dietary Supplements
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Alternative to Antibiotics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Alternative to Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Alternative to Antibiotics Market Overview
1.1 Alternative to Antibiotics Product Overview
1.2 Alternative to Antibiotics Market Segment by Type
1.2.1 Antimicrobial Proteins
1.2.2 Bacteriophages
1.2.3 Probiotics
1.2.4 Other
1.3 Global Alternative to Antibiotics Market Size by Type
1.3.1 Global Alternative to Antibiotics Market Size Overview by Type (2018-2029)
1.3.2 Global Alternative to Antibiotics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Alternative to Antibiotics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Alternative to Antibiotics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Alternative to Antibiotics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Alternative to Antibiotics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Alternative to Antibiotics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Alternative to Antibiotics Sales Breakdown by Type (2018-2023)
2 Global Alternative to Antibiotics Market Competition by Company
2.1 Global Top Players by Alternative to Antibiotics Sales (2018-2023)
2.2 Global Top Players by Alternative to Antibiotics Revenue (2018-2023)
2.3 Global Top Players by Alternative to Antibiotics Price (2018-2023)
2.4 Global Top Manufacturers Alternative to Antibiotics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Alternative to Antibiotics Market Competitive Situation and Trends
2.5.1 Alternative to Antibiotics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Alternative to Antibiotics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alternative to Antibiotics as of 2022)
2.7 Date of Key Manufacturers Enter into Alternative to Antibiotics Market
2.8 Key Manufacturers Alternative to Antibiotics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Alternative to Antibiotics Status and Outlook by Region
3.1 Global Alternative to Antibiotics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Alternative to Antibiotics Historic Market Size by Region
3.2.1 Global Alternative to Antibiotics Sales in Volume by Region (2018-2023)
3.2.2 Global Alternative to Antibiotics Sales in Value by Region (2018-2023)
3.2.3 Global Alternative to Antibiotics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Alternative to Antibiotics Forecasted Market Size by Region
3.3.1 Global Alternative to Antibiotics Sales in Volume by Region (2024-2029)
3.3.2 Global Alternative to Antibiotics Sales in Value by Region (2024-2029)
3.3.3 Global Alternative to Antibiotics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Alternative to Antibiotics by Application
4.1 Alternative to Antibiotics Market Segment by Application
4.1.1 Food & Beverage
4.1.2 Drugs
4.1.3 Dietary Supplements
4.2 Global Alternative to Antibiotics Market Size by Application
4.2.1 Global Alternative to Antibiotics Market Size Overview by Application (2018-2029)
4.2.2 Global Alternative to Antibiotics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Alternative to Antibiotics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Alternative to Antibiotics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Alternative to Antibiotics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Alternative to Antibiotics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Alternative to Antibiotics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Alternative to Antibiotics Sales Breakdown by Application (2018-2023)
5 North America Alternative to Antibiotics by Country
5.1 North America Alternative to Antibiotics Historic Market Size by Country
5.1.1 North America Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Alternative to Antibiotics Sales in Volume by Country (2018-2023)
5.1.3 North America Alternative to Antibiotics Sales in Value by Country (2018-2023)
5.2 North America Alternative to Antibiotics Forecasted Market Size by Country
5.2.1 North America Alternative to Antibiotics Sales in Volume by Country (2024-2029)
5.2.2 North America Alternative to Antibiotics Sales in Value by Country (2024-2029)
6 Europe Alternative to Antibiotics by Country
6.1 Europe Alternative to Antibiotics Historic Market Size by Country
6.1.1 Europe Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Alternative to Antibiotics Sales in Volume by Country (2018-2023)
6.1.3 Europe Alternative to Antibiotics Sales in Value by Country (2018-2023)
6.2 Europe Alternative to Antibiotics Forecasted Market Size by Country
6.2.1 Europe Alternative to Antibiotics Sales in Volume by Country (2024-2029)
6.2.2 Europe Alternative to Antibiotics Sales in Value by Country (2024-2029)
7 Asia-Pacific Alternative to Antibiotics by Region
7.1 Asia-Pacific Alternative to Antibiotics Historic Market Size by Region
7.1.1 Asia-Pacific Alternative to Antibiotics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Alternative to Antibiotics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Alternative to Antibiotics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Alternative to Antibiotics Forecasted Market Size by Region
7.2.1 Asia-Pacific Alternative to Antibiotics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Alternative to Antibiotics Sales in Value by Region (2024-2029)
8 Latin America Alternative to Antibiotics by Country
8.1 Latin America Alternative to Antibiotics Historic Market Size by Country
8.1.1 Latin America Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Alternative to Antibiotics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Alternative to Antibiotics Sales in Value by Country (2018-2023)
8.2 Latin America Alternative to Antibiotics Forecasted Market Size by Country
8.2.1 Latin America Alternative to Antibiotics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Alternative to Antibiotics Sales in Value by Country (2024-2029)
9 Middle East and Africa Alternative to Antibiotics by Country
9.1 Middle East and Africa Alternative to Antibiotics Historic Market Size by Country
9.1.1 Middle East and Africa Alternative to Antibiotics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Alternative to Antibiotics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Alternative to Antibiotics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Alternative to Antibiotics Forecasted Market Size by Country
9.2.1 Middle East and Africa Alternative to Antibiotics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Alternative to Antibiotics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 DSM
10.1.1 DSM Company Information
10.1.2 DSM Introduction and Business Overview
10.1.3 DSM Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 DSM Alternative to Antibiotics Products Offered
10.1.5 DSM Recent Development
10.2 DuPont(Danisco)
10.2.1 DuPont(Danisco) Company Information
10.2.2 DuPont(Danisco) Introduction and Business Overview
10.2.3 DuPont(Danisco) Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 DuPont(Danisco) Alternative to Antibiotics Products Offered
10.2.5 DuPont(Danisco) Recent Development
10.3 Chr. Hansen
10.3.1 Chr. Hansen Company Information
10.3.2 Chr. Hansen Introduction and Business Overview
10.3.3 Chr. Hansen Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Chr. Hansen Alternative to Antibiotics Products Offered
10.3.5 Chr. Hansen Recent Development
10.4 Lallemand
10.4.1 Lallemand Company Information
10.4.2 Lallemand Introduction and Business Overview
10.4.3 Lallemand Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Lallemand Alternative to Antibiotics Products Offered
10.4.5 Lallemand Recent Development
10.5 China-Biotics
10.5.1 China-Biotics Company Information
10.5.2 China-Biotics Introduction and Business Overview
10.5.3 China-Biotics Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 China-Biotics Alternative to Antibiotics Products Offered
10.5.5 China-Biotics Recent Development
10.6 Nestle
10.6.1 Nestle Company Information
10.6.2 Nestle Introduction and Business Overview
10.6.3 Nestle Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Nestle Alternative to Antibiotics Products Offered
10.6.5 Nestle Recent Development
10.7 Danone
10.7.1 Danone Company Information
10.7.2 Danone Introduction and Business Overview
10.7.3 Danone Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Danone Alternative to Antibiotics Products Offered
10.7.5 Danone Recent Development
10.8 Probi
10.8.1 Probi Company Information
10.8.2 Probi Introduction and Business Overview
10.8.3 Probi Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Probi Alternative to Antibiotics Products Offered
10.8.5 Probi Recent Development
10.9 BioGaia
10.9.1 BioGaia Company Information
10.9.2 BioGaia Introduction and Business Overview
10.9.3 BioGaia Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 BioGaia Alternative to Antibiotics Products Offered
10.9.5 BioGaia Recent Development
10.10 Yakult
10.10.1 Yakult Company Information
10.10.2 Yakult Introduction and Business Overview
10.10.3 Yakult Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Yakult Alternative to Antibiotics Products Offered
10.10.5 Yakult Recent Development
10.11 Novozymes
10.11.1 Novozymes Company Information
10.11.2 Novozymes Introduction and Business Overview
10.11.3 Novozymes Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Novozymes Alternative to Antibiotics Products Offered
10.11.5 Novozymes Recent Development
10.12 Valio
10.12.1 Valio Company Information
10.12.2 Valio Introduction and Business Overview
10.12.3 Valio Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Valio Alternative to Antibiotics Products Offered
10.12.5 Valio Recent Development
10.13 Glory Biotech
10.13.1 Glory Biotech Company Information
10.13.2 Glory Biotech Introduction and Business Overview
10.13.3 Glory Biotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Glory Biotech Alternative to Antibiotics Products Offered
10.13.5 Glory Biotech Recent Development
10.14 Ganeden
10.14.1 Ganeden Company Information
10.14.2 Ganeden Introduction and Business Overview
10.14.3 Ganeden Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Ganeden Alternative to Antibiotics Products Offered
10.14.5 Ganeden Recent Development
10.15 Morinaga Milk Industry
10.15.1 Morinaga Milk Industry Company Information
10.15.2 Morinaga Milk Industry Introduction and Business Overview
10.15.3 Morinaga Milk Industry Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Morinaga Milk Industry Alternative to Antibiotics Products Offered
10.15.5 Morinaga Milk Industry Recent Development
10.16 Sabinsa
10.16.1 Sabinsa Company Information
10.16.2 Sabinsa Introduction and Business Overview
10.16.3 Sabinsa Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Sabinsa Alternative to Antibiotics Products Offered
10.16.5 Sabinsa Recent Development
10.17 Greentech
10.17.1 Greentech Company Information
10.17.2 Greentech Introduction and Business Overview
10.17.3 Greentech Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Greentech Alternative to Antibiotics Products Offered
10.17.5 Greentech Recent Development
10.18 Bioriginal
10.18.1 Bioriginal Company Information
10.18.2 Bioriginal Introduction and Business Overview
10.18.3 Bioriginal Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Bioriginal Alternative to Antibiotics Products Offered
10.18.5 Bioriginal Recent Development
10.19 Biosearch Life
10.19.1 Biosearch Life Company Information
10.19.2 Biosearch Life Introduction and Business Overview
10.19.3 Biosearch Life Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Biosearch Life Alternative to Antibiotics Products Offered
10.19.5 Biosearch Life Recent Development
10.20 UAS Laboratories
10.20.1 UAS Laboratories Company Information
10.20.2 UAS Laboratories Introduction and Business Overview
10.20.3 UAS Laboratories Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.20.4 UAS Laboratories Alternative to Antibiotics Products Offered
10.20.5 UAS Laboratories Recent Development
10.21 Synbiotech
10.21.1 Synbiotech Company Information
10.21.2 Synbiotech Introduction and Business Overview
10.21.3 Synbiotech Alternative to Antibiotics Sales, Revenue and Gross Margin (2018-2023)
10.21.4 Synbiotech Alternative to Antibiotics Products Offered
10.21.5 Synbiotech Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Alternative to Antibiotics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Alternative to Antibiotics Industrial Chain Analysis
11.4 Alternative to Antibiotics Market Dynamics
11.4.1 Alternative to Antibiotics Industry Trends
11.4.2 Alternative to Antibiotics Market Drivers
11.4.3 Alternative to Antibiotics Market Challenges
11.4.4 Alternative to Antibiotics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Alternative to Antibiotics Distributors
12.3 Alternative to Antibiotics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock